Related Experiment Video
Updated: Aug 31, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Targeting glioblastoma through nano- and micro-particle-mediated immune modulation.
Ellen Poot1, Ander Maguregui2, Valerie G Brunton3
1School of Chemistry, The University of Edinburgh, Joseph Black Building, David Brewster Road, Edinburgh EH9 3FJ, UK; Centre for Discovery Brain Sciences, The University of Edinburgh, 49 Little France Crescent, Edinburgh EH16 4SB, UK.
Particle delivery systems offer a novel approach to overcome the blood-brain barrier (BBB) and deliver immunotherapies for Glioblastoma Multiforme (GBM). This strategy aims to improve treatment efficacy for this aggressive brain cancer.
Area of Science:
- Neuro-oncology
- Nanomedicine
- Immunotherapy
Background:
- Glioblastoma Multiforme (GBM) presents significant treatment challenges due to its complexity and the blood-brain barrier (BBB).
- Current GBM treatments have seen limited progress, with a low 5-year survival rate, highlighting the need for innovative therapeutic strategies.
- The immunosuppressive tumor microenvironment in GBM complicates treatment, with ongoing debate regarding the optimal immune modulation approach (pro-inflammatory vs. anti-inflammatory).
Purpose of the Study:
- To review recent advancements (past 3 years) in combining particle delivery systems with immunotherapy for GBM treatment.
- To explore how particle-based systems can overcome the BBB and deliver immunomodulatory agents to GBM tumors.
- To assess the potential of these combined approaches to improve therapeutic outcomes in GBM.
Main Methods:
- Systematic literature review focusing on studies published within the last three years.
- Analysis of research combining nanotechnology-based particle delivery systems with various immunotherapeutic agents.
- Evaluation of studies addressing BBB penetration and immune modulation in the context of GBM treatment.
Main Results:
- Particle delivery systems demonstrate potential in crossing the BBB, a critical hurdle in brain tumor treatment.
- Various immune-stimulatory molecules delivered via particles show promise in modulating the GBM immune microenvironment.
- Emerging evidence suggests synergistic effects when particle-based delivery is combined with immunotherapy for GBM.
Conclusions:
- Particle delivery systems represent a promising strategy to enhance immunotherapy delivery across the BBB for GBM.
- Further research into optimizing particle design and payload is crucial for clinical translation.
- The combination of particle delivery and immunotherapy holds potential to overcome current treatment limitations for Glioblastoma Multiforme.
More Related Videos
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010